Ogivri
Kit
- Prescription only
- Active substance
- Trastuzumab
- Made by
- Mylan Institutional LLC
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
This information is not included in the verified source. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Herceptin). It describes the substance, not this exact product.
The HER2 (or c-erbB2) proto-oncogene encodes a transmembrane receptor protein of 185 kDa, which is structurally related to the epidermal growth factor receptor.
Herceptin has been shown, in both in vitro assays and in animals, to inhibit the proliferation of human tumor cells that overexpress HER2.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-05-29
Safety of the active substance
From the US prescribing label for the same active substance (Herceptin). It describes the substance, not this exact product.
Evaluate cardiac function prior to and during treatment.
Most common adverse reactions (≥ 10%) are fever, chills, headache, infection, congestive heart failure, insomnia, cough, and rash.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
FranceNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Mylan Institutional LLC |
|---|---|
| Active substance | Trastuzumab |
| Form | Kit |
| Packs | 1 KIT in 1 CARTON * 20 mL in 1 VIAL, MULTI-DOSE * 20 mL in 1 VIAL |
| NDC | 67457-847 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
5 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Injection, Powder, Lyophilized, for Solution3 products
150 mg/7.4mL2
150 mg/7.4mL · 2 companies
- 420 mg/20mL
- Kit2 products
—2
— · 2 companies
- Biocon Biologics Inc.
- Mylan Institutional LLC · this page
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.